Citations 1
Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity
Ma, Xiao , Zhu, Ping , Zhang, Hong , Qiu, Qi , Dvornikov, Alexey V. , Wang, Zheng , Wang, Yong , Lowerison, Matthew R. , Yu, Yue , Norton, Nadine , Herrmann, Joerg , Ekker, Stephen C. , Ding, Yonghe , Zhang, Hong , Qiu, Qi , Dvornikov, Alexey V , Wang, Zheng , Kim, Maengjo , Lowerison, Matthew , Ekker, Stephen C , Lin, Xueying , Ma, Xiao , Hsiai, Tzung K. , Xu, Xiaolei , Norton, Nadine
Science Advances | January 30, 2020 | Volume: 6 | Issue: 5 | Pages: No page available
RXRA is an endothelial- and early stage–predominant therapeutic target for treating anthracycline-induced cardiotoxicity.